SCHEMBL19791859

SCHEMBL19791859

CC(C=O)NC(=O)CCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC2 Q92769 1/20 0.54
▸ HDAC8 Q9BY41 1/20 0.54
▸ HDAC6 Q9UBN7 1/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ RAB9A P51151 1/20 0.52
▸ HDAC1 Q13547 3/20 0.51
▸ HTT P42858 2/20 0.51
▸ MAPT P10636 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ CTSB P07858 1/20 0.51
▸ HDAC3 O15379 1/20 0.50
▸ CNR2 P34972 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14997425 0.91 SMN1; SMN2 (0.67) HDAC2HDAC8HDAC6SMN1; SMN2HDAC1
SCHEMBL14997400 0.91 SMN1; SMN2 (0.67) HDAC2HDAC8HDAC6SMN1; SMN2HDAC1
SCHEMBL7300117 0.84 HDAC2 (0.51) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A
SCHEMBL3024849 0.83 POLB (0.59) MAPTALDH1A1CNR2CYP1A2KDM4E
SCHEMBL3024846 0.83 POLB (0.59) MAPTALDH1A1CNR2CYP1A2KDM4E
SCHEMBL13054604 0.83 SMN1; SMN2 (0.50) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A
SCHEMBL13054596 0.83 SMN1; SMN2 (0.50) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A
SCHEMBL7772333 0.83 ALDH1A1 (0.66) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A
SCHEMBL24114487 0.81 SMN1; SMN2 (0.58) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A
SCHEMBL18759290 0.81 SMN1; SMN2 (0.58) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3272749-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE Bayer Pharma Aktiengesellschaft (DE) 2018-01-24 — — EP disclosed
Send feedback